Corrigendum to “Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines” [Leukemia Res. 128, 107054]

Publication date: Available online 29 May 2023Source: Leukemia ResearchAuthor(s): Raveen Stephen Stallon Illangeswaran, Daniel Zechariah Paul Jebanesan, Kezia Kanimozhi Sivakumar, Rakhi Thalayattu Vidhyadharan, Bharathi M. Rajamani, Nancy Beryl Janet, …

Outcomes with Molecularly Targeted Agents as Salvage Therapy Following Frontline Venetoclax + Hypomethylating Agent in Adults with Acute Myeloid Leukemia: A Multicenter Retrospective Analysis

Publication date: Available online 29 May 2023Source: Leukemia ResearchAuthor(s): Vishesh Khanna, Tali Azenkot, Selina (Qiuying) Liu, Jason Gilbert, Edna Cheung, Kimberly Lau, Daniel A Pollyea, Elie Traer, Brian A Jonas, Tian Y Zhang, Gabriel N Mannis

Comparison of a Modified Pediatric Protocol versus a Hyper-CVAD Protocol in Adolescents and Young Adults with Philadelphia-negative Acute Lymphoblastic Leukemia: A Multicenter Retrospective Analysis

Publication date: Available online 20 May 2023Source: Leukemia ResearchAuthor(s): Hind Salama, Saleem Eldadah, Mohamed H. Omer, Ayman Hejazi, Luluh Bin Dayil, Ayman Almozaini, Roaa Reda Khalil, Areej Al Mugairi, Mohammed Snnallah, Moussab Damlaj, Ahmed…

Specific Immune Response to mRNA Vaccines Against COVID-19 in Patients Receiving Allogeneic Stem Cell Transplantation for Myeloid Malignancy Was Altered by Immunosuppressive Therapy

Publication date: Available online 16 May 2023Source: Leukemia ResearchAuthor(s): Jana Macková, Petr Hainz, Jitka Kryštofová, Kateřina Roubalová, Markéta Šťastná-Marková, Šárka Vaníková, Jan Musil, Jan Vydra, Šárka Němečková